FIELD: medicine; therapy; pulmonology; nephrology.
SUBSTANCE: invention relates to medicine, namely to therapy, pulmonology, nephrology; it can be used in the prediction of the development of chronic kidney disease (hereinafter – CKD) in individuals with chronic obstructive pulmonary disease (hereinafter – COPD). To do this, the patient’s quality of life is assessed in points by filling out the COPD Assessment Test questionnaire, the severity of dyspnea is assessed in points according to the British Medical Research Council scale, a number of exacerbations suffered by the patient over the previous 12 months is calculated, a level of leukocytes, concentration of chlorine ions, interleukin-6 and tumor necrosis factor α in the blood serum is determined. Then, three classifying discriminant equations are solved. Obtained results Y1, Y2, and Y3 are compared, and, if the maximum value is Y1, then, the patient with COPD is predicted to have a high probability of the development of CKD with a glomerular filtration rate (hereinafter – GFR)<60 ml/min/1.73 m2. If the maximum value is Y2, then the patient with COPD is predicted to have a high probability of the development of CKD with GFR≥60 ml/min/1.73 m2. If the maximum value is Y3, then the patient with COPD has no probability of the development of CKD.
EFFECT: method provides prediction of the probability of the development of CKD in individuals with COPD, based on an assessment of clinical and laboratory characteristics of COPD, which makes it possible to start preventive measures at an earlier stage, within 8 hours, preventing the development and further progression of CKD.
1 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SELECTION OF PATIENTS SUFFERING FROM CHRONIC OBSTRUCTIVE PULMONARY DISEASE "WITH RARE EXACERBATIONS" FOR TREATMENT OF ROFLUMILAST | 2019 |
|
RU2726228C1 |
METHOD FOR EARLY DIAGNOSIS OF ENDOTHELIAL RENAL DYSFUNCTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2020 |
|
RU2767701C1 |
METHOD FOR PREDICTION OF EFFECTIVE TREATMENT WITH ROFLUMILAST OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE PHENOTYPE "WITH FREQUENT EXACERBATIONS" | 2019 |
|
RU2712244C1 |
METHOD OF PERSONALIZED TREATMENT OF CHRONIC RENAL DISEASE IN PATIENTS WITH DIABETIC NEPHROPATHY | 2018 |
|
RU2687256C1 |
METHOD FOR PREVENTION OF EXACERBATION OF BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2016 |
|
RU2625744C1 |
METHOD FOR EARLY DIAGNOSTICS OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2016 |
|
RU2647327C2 |
METHOD FOR DIAGNOSTICS OF CHRONIC KIDNEY DISEASE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS | 2017 |
|
RU2641964C1 |
METHOD FOR PREDICTING RECRUDESCENCE OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN PATIENTS WITH INSOMNIA | 2018 |
|
RU2681272C1 |
METHOD OF TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2016 |
|
RU2609274C1 |
METHOD OF PREDICTING THE RISK OF DEVELOPMENT OF COMPLICATIONS IN THE EARLY HOSPITAL PERIOD OF PATIENTS AFTER CORONARY SHUNTING IN THE CONDITIONS OF ARTIFICIAL CIRCULATION | 2017 |
|
RU2642238C1 |
Authors
Dates
2022-06-21—Published
2020-09-23—Filed